Giritinib Dosage Guidelines + Maximum Dose, Adjustments

Gilitinib is a targeted therapy drug targeting FLT3 mutations. It is mainly used to treat FLT3-positive acute myeloid leukemia (AML). When using giritinib, dose selection and adjustment are critical to ensuring the drug's effectiveness and safety.

The recommended starting dose of giritinib is 120mg once a day, and every 28 days constitutes a treatment cycle. This dose is determined based on the patient's body surface area and the pharmacokinetic properties of the drug and is designed to provide optimal therapeutic efficacy while minimizing adverse effects.

During treatment, the doctor will adjust the dosage based on the patient's response and tolerance. If specific efficacy criteria (such as complete response or partial response) are not achieved after 4 weeks of treatment and the patient tolerates it, the physician may consider increasing the dose to 200 mg once daily. Dosage adjustments should be made with caution and patient response closely monitored. If intolerable toxic reactions occur, such as severe nausea, vomiting, diarrhea or liver function abnormalities, dose reduction or temporary discontinuation may be required.

Although the maximum recommended dose of giritinib is usually 200mg once daily, actual application should be determined based on the patient's specific situation and the doctor's recommendations. Patients are not advised to increase the dose on their own as this may increase the risk of adverse effects.

During the period of using giritinib, patients should undergo regular hematological, cytogenetic and molecular biology examinations in order to timely evaluate the efficacy and adjust the treatment plan.

Giritinib should be taken with or without food, but should be taken at approximately the same time each day to maintain stable blood concentrations.

If you miss one or more doses of gilitinib, you should take it as soon as possible, but the next scheduled dose should be at least 12 hours apart.

In summary, geritinib dose selection and adjustment is a complex process that requires comprehensive consideration of the patient's specific situation, efficacy, and safety. Patients should follow their doctor's instructions when using giritinib and undergo regular examinations to ensure the effectiveness and safety of the treatment.